Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003090887 | SCV003469553 | likely benign | Nemaline myopathy 2 | 2023-08-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003075399 | SCV003591324 | uncertain significance | Inborn genetic diseases | 2021-12-07 | criteria provided, single submitter | clinical testing | The c.10258C>T (p.R3420C) alteration is located in exon 71 (coding exon 69) of the NEB gene. This alteration results from a C to T substitution at nucleotide position 10258, causing the arginine (R) at amino acid position 3420 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV003134629 | SCV003812260 | uncertain significance | not provided | 2023-10-26 | criteria provided, single submitter | clinical testing | |
Gene |
RCV003134629 | SCV005371645 | uncertain significance | not provided | 2023-06-29 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |